3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Carcinoma, Hepatocellular
11
Stomach Neoplasms
10
Esophageal Squamous Cell Carcinoma
10
Squamous Cell Carcinoma of Head and Neck
9
Lung Neoplasms
8
Colorectal Neoplasms
8
Rectal Neoplasms
5
Advanced Solid Tumor
5
Head and Neck Neoplasms
4
Triple Negative Breast Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasm, Residual
2
Nasopharyngeal Carcinoma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Colonic Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Solid Tumour
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of External Auditory Canal
1
Solid Tumor, Adult
1
Solid Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Simpson-Golabi-Behmel syndrome
1
Sarcoma
1
Renal Pelvic Carcinoma
1
Interventions
zanidatamab
1
tislelizumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Muscle Invasive Bladder Cancer (MIBC)
×
tislelizumab
×
Clear all
NCT07296705
2025-12-22
HARBOR
Fujian Medical University Union Hospital
Phase 2
Recruiting
25 enrolled